A3921030
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for A3921030, covering 2018-02-23 to 2018-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients [Phase 2]